Fortress Biotech Announces Q2 2026 Financial Results

What Happened
Fortress Biotech, Inc. announced its financial results and provided a corporate update for the quarter ended June 30, 2026. The company furnished a press release as Exhibit 99.1 to an 8-K filed on August 13, 2026 (Item 2.02: Results of Operations and Financial Condition).

Key Details

• Filing date: August 13, 2026; quarter covered: ended June 30, 2026.
• Press release furnished as Exhibit 99.1 (information furnished, not “filed” under Section 18 of the Exchange Act).
• Cover page Interactive XBRL data included (Exhibit 104).
• 8-K signed by Chief Financial Officer David Jin.

Why It Matters
This 8-K signals that Fortress has released its latest quarterly earnings and corporate update; investors should review the furnished press release for revenue, earnings, and operational details. Because the release is furnished (not filed), it is provided for disclosure but is not subject to the liabilities of Section 18 — still, the press release is the primary source for the company’s reported quarterly results and guidance. Check the attached Exhibit 99.1 or the company’s SEC filings/press releases for the full financial figures and management commentary.